Colgate-Palmolive (NYSE:CL) Holdings Reduced by Private Trust Co. NA

Private Trust Co. NA cut its stake in Colgate-Palmolive (NYSE:CL) by 14.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,682 shares of the company’s stock after selling 1,655 shares during the period. Private Trust Co. NA’s holdings in Colgate-Palmolive were worth $880,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. State Street Corp boosted its holdings in shares of Colgate-Palmolive by 3.8% in the third quarter. State Street Corp now owns 48,436,276 shares of the company’s stock valued at $5,028,170,000 after acquiring an additional 1,784,411 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of Colgate-Palmolive by 2.8% in the third quarter. Geode Capital Management LLC now owns 20,193,331 shares of the company’s stock valued at $2,095,325,000 after acquiring an additional 552,949 shares in the last quarter. Massachusetts Financial Services Co. MA boosted its holdings in shares of Colgate-Palmolive by 6.2% in the third quarter. Massachusetts Financial Services Co. MA now owns 9,526,990 shares of the company’s stock valued at $988,997,000 after acquiring an additional 557,492 shares in the last quarter. Barclays PLC boosted its holdings in shares of Colgate-Palmolive by 38.7% in the third quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock valued at $793,542,000 after acquiring an additional 2,132,747 shares in the last quarter. Finally, FMR LLC lifted its stake in Colgate-Palmolive by 65.6% during the third quarter. FMR LLC now owns 6,749,275 shares of the company’s stock valued at $700,642,000 after purchasing an additional 2,674,807 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Stock Performance

Shares of NYSE CL opened at $91.27 on Friday. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. Colgate-Palmolive has a one year low of $85.32 and a one year high of $109.30. The business’s 50-day moving average price is $88.74 and its two-hundred day moving average price is $95.51. The company has a market capitalization of $74.07 billion, a P/E ratio of 25.93, a price-to-earnings-growth ratio of 4.20 and a beta of 0.44.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the previous year, the business posted $0.87 earnings per share. Analysts anticipate that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st were paid a dividend of $0.50 per share. The ex-dividend date of this dividend was Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.19%. Colgate-Palmolive’s dividend payout ratio (DPR) is 56.82%.

Analyst Ratings Changes

Several research firms recently commented on CL. JPMorgan Chase & Co. cut their target price on shares of Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a research note on Monday, February 3rd. Stifel Nicolaus cut their target price on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research note on Monday, February 3rd. Morgan Stanley cut their target price on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a research note on Monday, February 3rd. Raymond James reissued an “outperform” rating and set a $105.00 target price (down from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. Finally, UBS Group cut their target price on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research note on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat, Colgate-Palmolive has an average rating of “Hold” and an average target price of $101.16.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.